4/A//SEC Filing
Galante Joseph C 4/A
Accession 0001628280-25-003185
CIK 0001087294other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 4:39 PM ET
Size
5.0 KB
Accession
0001628280-25-003185
Insider Transaction Report
Form 4/AAmended
Galante Joseph C
Director
Transactions
- Award
Common Stock
2024-03-25$1.71/sh+2,500$4,275→ 60,856 total
Footnotes (1)
- [F1]This amendment is being filed solely to correct an administrative error in reporting the number of Securities Acquired by Reporting Owner on the original Form 4 submitted on March 26, 2024, which were reported as 1,000 shares granted on March 25, 2024, but should have been reported as 2,500 shares. This reflects an increase of 1,500 shares.
Documents
Issuer
CUMBERLAND PHARMACEUTICALS INC
CIK 0001087294
Entity typeother
Related Parties
1- filerCIK 0001632384
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 4:39 PM ET
- Size
- 5.0 KB